CoChat

Fear of progression in patients with gastrointestinal stromal tumors (GIST): Is extended lifetime related to the Sword of Damocles?

Open access
Custers, José A. E., Tielen, Ronald, Prins, Judith B., de Wilt, Johannes H. W., Gielissen, Marieke F. M., van der Graaf, Winette T. A. · 2015 · Acta Oncologica
Cited by 38

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Gastrointestinal stromal tumors (GIST) are rare and before 2000, patients had a dismal prognosis with a median survival of less than a year after tumor metastasis. However, the median overall survival has increased to more than five years following the introduction of imatinib and other tyrosine kinase inhibitors (TKI). Little is known about the psychosocial consequences of treatment of GIST, but this is important because patients now are treated and live for longer. This cross-sectional study assessed quality of life, distress, and fear of cancer recurrence or progression in patients with GIST. MATERIAL AND METHODS: Eighty-six patients with localized or metastatic GIST were asked to participate. Patients completed self-report questionnaires including the EORTC-Quality of Life Questionnaire, Hospital Anxiety and Depression Scale, Impact of Event Scale, Cancer Worry Scale, and Fear of Cancer Recurrence Inventory. RESULTS: Fifty-four patients (median age 63.3 years) completed the questionnaires, 33 (61%) of whom were receiving TKI treatment at the time of the study. Overall, the GIST patients had a good global quality of life, but 28 patients had high levels of fear of cancer recurrence/progression. This high level of fear was not related to patient- or treatment-related variables. These patients experienced significantly higher levels of psychological distress, functional impairments, and difficulty making plans for the future than did patients with lower levels of fear. CONCLUSIONS: More attention should be paid to specific cancer-related problems, such as fear of cancer recurrence/progression, in addition to general quality of life issues in patients with GIST.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/0284186x.2014.1003960

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 21

  1. Demetri GD, 2010, J Natl Compr Canc Netw, 8, S1, 10.6004/jnccn.2010.0116 · DOI · Paper page
  2. 10.1038/nrclinonc.2012.74 · DOI
  3. 10.1016/S0140-6736(09)60500-6 · DOI · Paper page
  4. Corless CL, 2011, Nat Rev Cancer, 11, 865, 10.1038/nrc3143 · DOI · Paper page
  5. 10.1002/jso.21930 · DOI
  6. 10.1056/NEJMoa020461 · DOI · Paper page
  7. 10.1001/jama.2012.347 · DOI · Paper page
  8. 10.1016/S0140-6736(06)69446-4 · DOI · Paper page
  9. 10.1016/S0140-6736(12)61857-1 · DOI · Paper page
  10. 10.1200/JCO.2007.13.4403 · DOI · Paper page
  11. 10.1002/pon.1481 · DOI · Paper page
  12. 10.1002/pon.1570 · DOI · Paper page
  13. 10.1097/NCC.0b013e3182813a17 · DOI · Paper page
  14. 10.1093/jnci/85.5.365 · DOI · Paper page
  15. Osoba D, 1998, J Clin Oncol, 16, 139, 10.1200/JCO.1998.16.1.139 · DOI · Paper page
  16. 10.1007/s00520-011-1251-4 · DOI · Paper page
  17. 10.1037/1040-3590.16.1.16 · DOI · Paper page
  18. 10.1007/s00520-012-1426-7 · doi:10.1007/s00520-012-1426-7
  19. Fayers PM, 2001, EORTC QLQ-C30 Scoring Manual
  20. Macdonald N, 2012, Patient Prefer Adherence, 6, 253
  21. Case DO, 2005, J Med Libr Assoc, 93, 352

Cited by

See all 38

Metadata

Authors
Custers, J. A. E., Tielen, R., Prins, J. B., de Wilt, J. H. W., Gielissen, M. F. M., & van der Graaf, W. T. A.
Venue
Acta Oncologica
Published
2015-03-03
Volume
54
Issue
8
Pages
1202-1208
ISSN
  • 0284-186X (ISSN-L)
  • 1651-226X
OpenAlex
W2172182188
Cited by
38
References
4
FWCI
1.04
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fear of progression in patients with gastrointestinal stromal tumors (GIST): Is extended lifetime related to the Sword of Damocles? https://app.cochat.ai/papers/10.3109/0284186x.2014.1003960
The paper
Custers, J. A. E., Tielen, R., Prins, J. B., de Wilt, J. H. W., Gielissen, M. F. M., & van der Graaf, W. T. A. (2015). Fear of progression in patients with gastrointestinal stromal tumors (GIST): Is extended lifetime related to the Sword of Damocles? Acta Oncologica. https://doi.org/10.3109/0284186x.2014.1003960

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.